Quantcast
Last updated on April 16, 2014 at 12:50 EDT

Latest Capecitabine Stories

2007-01-23 15:00:58

Preliminary results show the combination of Xeloda plus Eloxatin, known as XELOX, to be equivalent to standard FOLFOX-4 chemotherapy treatment in terms of overall survival in first-line metastatic colorectal cancer patients. Given its dosing convenience advantage, XELOX has the potential to be a first-line treatment, provided it can be demonstrated as cost-effective. The 2,034 metastatic colorectal cancer patient study was originally designed to compare first-line XELOX (Roche/Chugai's...

2006-04-06 03:40:00

ZURICH -- Drugmaker Roche Holding AG said on Thursday its Xeloda oral chemotherapy was as effective as standard drugs in treating advanced stomach cancer, supporting analysts' views of higher sales potential. Roche said data from a Phase III study due to be presented at an American Society of Clinical Oncology meeting (ASCO) showed that Xeloda, when added to another chemotherapy called cisplatin, was at least as effective as the intravenous chemotherapy drug, 5-fluorouracil. Gastric cancer is...